Cargando…
Role of carnitine in disease
Carnitine is a conditionally essential nutrient that plays a vital role in energy production and fatty acid metabolism. Vegetarians possess a greater bioavailability than meat eaters. Distinct deficiencies arise either from genetic mutation of carnitine transporters or in association with other diso...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861661/ https://www.ncbi.nlm.nih.gov/pubmed/20398344 http://dx.doi.org/10.1186/1743-7075-7-30 |
_version_ | 1782180656441196544 |
---|---|
author | Flanagan, Judith L Simmons, Peter A Vehige, Joseph Willcox, Mark DP Garrett, Qian |
author_facet | Flanagan, Judith L Simmons, Peter A Vehige, Joseph Willcox, Mark DP Garrett, Qian |
author_sort | Flanagan, Judith L |
collection | PubMed |
description | Carnitine is a conditionally essential nutrient that plays a vital role in energy production and fatty acid metabolism. Vegetarians possess a greater bioavailability than meat eaters. Distinct deficiencies arise either from genetic mutation of carnitine transporters or in association with other disorders such as liver or kidney disease. Carnitine deficiency occurs in aberrations of carnitine regulation in disorders such as diabetes, sepsis, cardiomyopathy, malnutrition, cirrhosis, endocrine disorders and with aging. Nutritional supplementation of L-carnitine, the biologically active form of carnitine, is ameliorative for uremic patients, and can improve nerve conduction, neuropathic pain and immune function in diabetes patients while it is life-saving for patients suffering primary carnitine deficiency. Clinical application of carnitine holds much promise in a range of neural disorders such as Alzheimer's disease, hepatic encephalopathy and other painful neuropathies. Topical application in dry eye offers osmoprotection and modulates immune and inflammatory responses. Carnitine has been recognized as a nutritional supplement in cardiovascular disease and there is increasing evidence that carnitine supplementation may be beneficial in treating obesity, improving glucose intolerance and total energy expenditure. |
format | Text |
id | pubmed-2861661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28616612010-04-30 Role of carnitine in disease Flanagan, Judith L Simmons, Peter A Vehige, Joseph Willcox, Mark DP Garrett, Qian Nutr Metab (Lond) Review Carnitine is a conditionally essential nutrient that plays a vital role in energy production and fatty acid metabolism. Vegetarians possess a greater bioavailability than meat eaters. Distinct deficiencies arise either from genetic mutation of carnitine transporters or in association with other disorders such as liver or kidney disease. Carnitine deficiency occurs in aberrations of carnitine regulation in disorders such as diabetes, sepsis, cardiomyopathy, malnutrition, cirrhosis, endocrine disorders and with aging. Nutritional supplementation of L-carnitine, the biologically active form of carnitine, is ameliorative for uremic patients, and can improve nerve conduction, neuropathic pain and immune function in diabetes patients while it is life-saving for patients suffering primary carnitine deficiency. Clinical application of carnitine holds much promise in a range of neural disorders such as Alzheimer's disease, hepatic encephalopathy and other painful neuropathies. Topical application in dry eye offers osmoprotection and modulates immune and inflammatory responses. Carnitine has been recognized as a nutritional supplement in cardiovascular disease and there is increasing evidence that carnitine supplementation may be beneficial in treating obesity, improving glucose intolerance and total energy expenditure. BioMed Central 2010-04-16 /pmc/articles/PMC2861661/ /pubmed/20398344 http://dx.doi.org/10.1186/1743-7075-7-30 Text en Copyright ©2010 Flanagan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Flanagan, Judith L Simmons, Peter A Vehige, Joseph Willcox, Mark DP Garrett, Qian Role of carnitine in disease |
title | Role of carnitine in disease |
title_full | Role of carnitine in disease |
title_fullStr | Role of carnitine in disease |
title_full_unstemmed | Role of carnitine in disease |
title_short | Role of carnitine in disease |
title_sort | role of carnitine in disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861661/ https://www.ncbi.nlm.nih.gov/pubmed/20398344 http://dx.doi.org/10.1186/1743-7075-7-30 |
work_keys_str_mv | AT flanaganjudithl roleofcarnitineindisease AT simmonspetera roleofcarnitineindisease AT vehigejoseph roleofcarnitineindisease AT willcoxmarkdp roleofcarnitineindisease AT garrettqian roleofcarnitineindisease |